Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment

Seung Woo Kim,Chan Woo Kim,Young-Ah Moon,Hong Seok Kim
DOI: https://doi.org/10.1080/19768354.2024.2336249
2024-04-04
Animal Cells and Systems
Abstract:The tumor microenvironment comprises both tumor and non-tumor stromal cells, including tumor-associated macrophages (TAMs), endothelial cells, and carcinoma-associated fibroblasts. TAMs, major components of non-tumor stromal cells, play a crucial role in creating an immunosuppressive environment by releasing cytokines, chemokines, growth factors, and immune checkpoint proteins that inhibit T cell activity. During tumors develop, cancer cells release various mediators, including chemokines and metabolites, that recruit monocytes to infiltrate tumor tissues and subsequently induce an M2-like phenotype and tumor-promoting properties. Metabolites are often overlooked as metabolic waste or detoxification products but may contribute to TAM polarization. Furthermore, macrophages display a high degree of plasticity among immune cells in the tumor microenvironment, enabling them to either inhibit or facilitate cancer progression. Therefore, TAM-targeting has emerged as a promising strategy in tumor immunotherapy. This review provides an overview of multiple representative metabolites involved in TAM phenotypes, focusing on their role in pro-tumoral polarization of M2.
cell biology,zoology
What problem does this paper attempt to address?
The problem this paper attempts to address is how metabolites in the tumor microenvironment reprogram the functions of tumor-associated macrophages (TAMs), particularly their role in promoting M2 macrophage polarization. Specifically, the paper explores the following points: 1. **The role of TAMs in the tumor microenvironment**: TAMs are the main component of non-tumor stromal cells in the tumor microenvironment. By releasing substances such as cytokines, chemokines, growth factors, and immune checkpoint proteins, they create an immunosuppressive environment that inhibits T cell activity and promotes tumor development. 2. **The role of metabolites in TAM polarization**: During the development of cancer, cancer cells release various mediators, including chemokines and metabolites. These metabolites can recruit monocytes into the tumor tissue and induce their transformation into an M2-like phenotype with pro-tumor characteristics. Although metabolites are usually considered metabolic waste or detoxification products, they may have a significant impact on TAM polarization. 3. **Plasticity of TAMs**: Macrophages exhibit high plasticity in the tumor microenvironment, capable of displaying different polarization states based on environmental signals, such as pro-inflammatory M1 type and anti-inflammatory M2 type. This plasticity allows TAMs to both inhibit and promote cancer development. Therefore, therapeutic strategies targeting TAMs show great potential in tumor immunotherapy. 4. **Mechanisms of representative metabolites**: The paper details the mechanisms of various metabolites in TAM polarization, including lactate, succinate, α-ketoglutarate, itaconate, adenosine, and lipid metabolites (such as prostaglandin E2 and sphingosine-1-phosphate). These metabolites influence TAM polarization through different signaling pathways, thereby affecting tumor development. In summary, this paper aims to delve into how metabolites in the tumor microenvironment reprogram the functions of TAMs, particularly the specific mechanisms by which these metabolites promote M2 macrophage polarization, providing a theoretical basis for the development of new tumor immunotherapy methods.